The Real World Study for TACE combined with Apatinib in the treatment of advanced hepatocarcinoma in He'nan Province
Latest Information Update: 25 Feb 2021
At a glance
- Drugs Rivoceranib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
Most Recent Events
- 25 Feb 2021 Status changed from not yet recruiting to recruiting results presented at the 2021 Gastrointestinal Cancers Symposium
- 17 Jan 2021 Results presented at the 2021 Gastrointestinal Cancers Symposium
- 01 Oct 2019 New trial record